SMMT
Summit Therapeutics PLC
NASDAQ: SMMT · HEALTHCARE · BIOTECHNOLOGY
$21.46
+3.02% today
Updated 2026-04-30
Market cap
$16.50B
P/E ratio
—
P/S ratio
3,891.31x
EPS (TTM)
$-1.44
Dividend yield
—
52W range
$14 – $31
Volume
3.1M
Summit Therapeutics PLC (SMMT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-206.10%
ROA
-115.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $2.03M | $-5.92M | 70.61% | -423.82% | -292.11% |
| 2007 | $6.03M | $-20.13M | 1.95% | -388.46% | -334.07% |
| 2008 | $266639.00 | $-32.29M | 97.84% | -7,198.87% | -12,109.63% |
| 2009 | $301945.00 | $-5.34M | -706.85% | -3,047.57% | -1,769.24% |
| 2010 | $1.21M | $-7.42M | 100.00% | -777.38% | -614.91% |
| 2011 | $1.79M | $-4.23M | 89.35% | -263.81% | -236.72% |
| 2012 | $2.87M | $-6.67M | 66.14% | -159.76% | -232.91% |
| 2013 | $2.27M | $-6.09M | 81.31% | -295.81% | -268.65% |
| 2014 | $1.89M | $-17.12M | 100.00% | -647.93% | -906.83% |
| 2015 | $1.28M | $-24.34M | 100.00% | -1,588.29% | -1,899.84% |
| 2016 | $2.88M | $-22.72M | 100.00% | -1,078.65% | -788.76% |
| 2017 | $14.17M | $-28.53M | 100.00% | -182.31% | -201.39% |
| 2018 | $57.09M | $10.87M | 98.77% | 9.44% | 19.04% |
| 2019 | $43.01M | $4.99M | 100.00% | 35.24% | 11.61% |
| 2020 | $860000.00 | $-52.70M | 100.00% | -8,330.93% | -6,127.56% |
| 2021 | $1.81M | $-86.15M | 100.00% | -4,764.29% | -4,762.13% |
| 2022 | $704295.00 | $-78.78M | -256.99% | -11,259.77% | -11,185.94% |
| 2023 | $0.00 | $-614.93M | — | — | — |
| 2024 | $0.00 | $-221.31M | — | — | — |
| 2025 | $0.00 | $-1.08B | — | — | — |